ArkeaBio
1 known investors
ArkeaBio develops a methane-reducing vaccine for cattle that lowers agricultural emissions without disrupting farm operations, targeting livestock producers to enable low-carbon dairy and beef production. The vaccine activates a natural immune response in ruminants and integrates seamlessly with existing farming practices.
Founders & leadership
FW
Frank WootenChief Executive Officer
ZS
Zach SerberChief Technology Officer
CS
Colin SouthChief Business Officer
Investors · 1
Frequently asked questions
- What does ArkeaBio do?
- ArkeaBio develops a methane-reducing vaccine for cattle that lowers agricultural emissions without disrupting farm operations, targeting livestock producers to enable low-carbon dairy and beef production. The vaccine activates a natural immune response in ruminants and integrates seamlessly with existing farming practices.
- Who are ArkeaBio's investors?
- ArkeaBio's investors include Breakthrough Energy Ventures.